BioCentury
ARTICLE | Product Development

China’s clinical talent gap

How Chinese companies are finding the clinical experts they need to run local trials

December 21, 2018 9:31 PM UTC

While regulatory changes in China have helped clear the way for rapid growth of its clinical trial infrastructure, the country’s dearth of clinical experts could hold back the expansion until new talent is up to speed. The shortfall could to take up to five years to resolve.

Last year, China’s National Medical Products Administration (NMPA) made it easier to qualify hospitals to run clinical trials and shortened the time it takes to start Phase I testing. But stakeholders contacted by BioCentury think there aren’t enough clinical trial experts in the country to take advantage of the changes. ...